Related Experiment Video

Updated: Jun 5, 2026

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

Pseudoaneurysms of the mitral-aortic intervalvular fibrosa: survival without reoperation

Amy Gin1, Helen Hong, Andrew Rosenblatt

  • 1Department of Cardiology, California PAcific Medical Center, San Francisco, CA, USA. ginal@sutterhealth.org

American Heart Journal
|December 21, 2010
PubMed
Abstract

Insights

Mitral-aortic intervalvular fibrosa (MAIVF) pseudoaneurysms can be monitored non-surgically. Clinical surveillance and serial imaging may be a safe alternative to surgery for select patients with MAIVF pseudoaneurysms.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Medical Imaging

Background:

  • The mitral-aortic intervalvular fibrosa (MAIVF) is a potential site for pseudoaneurysm formation.
  • Pseudoaneurysms in this region can arise from infective endocarditis, congenital heart disease, or post-valve surgery.
  • Surgical repair is often recommended due to potential complications of MAIVF pseudoaneurysms.

Observation:

  • Three patients with MAIVF pseudoaneurysms were managed conservatively without surgical intervention.
  • The pseudoaneurysms remained stable in size over several years in all three patients.
  • Surgical risk was deemed too high for two patients, and the third declined further surgery.

Findings:

  • MAIVF pseudoaneurysms demonstrated stable dimensions ranging from 4.8 × 2.5 cm to 7.6 × 4.9 cm over time.
  • Two of the three patients remained asymptomatic during the follow-up period.
  • The third patient, diagnosed at 87, died of non-cardiac causes at 92, with the pseudoaneurysm being stable.

Implications:

  • Clinical surveillance and serial imaging represent a viable alternative to surgical management for select MAIVF pseudoaneurysm cases.
  • Conservative management may be considered when surgical risks are high or patient preference dictates.
  • This approach highlights the potential for non-invasive monitoring in specific cardiovascular conditions.

More Related Videos

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

Arterial Pouch Microsurgical Bifurcation Aneurysm Model in the Rabbit06:11

Arterial Pouch Microsurgical Bifurcation Aneurysm Model in the Rabbit

Published on: May 14, 2020

Related Concept Videos

Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...